Med-South Lifestyle Program for Pregnancy

August 21, 2025 updated by: University of North Carolina, Chapel Hill

A Pilot Study of a Food is Medicine Intervention to Improve Pregnancy Outcomes

Eating a Mediterranean-style diet during pregnancy improves pregnancy outcomes, yet most Americans who are pregnant do not follow this type of dietary pattern. There is increasing interest in Food is Medicine programs, which provides foods to patients to improve health outcomes - food provided in this context is called medically tailored meals. The research team at the UNC Center for Health Promotion and Disease Prevention is developing a Food is Medicine program to improve pregnancy outcomes and at this point the team is ready to test the program.

The purpose of this study is to assess the feasibility and acceptability of a Food is Medicine intervention when started during the first trimester of pregnancy. The eating pattern to be evaluated in this study is a Mediterranean-style dietary pattern adapted for the southern United States - thus, the program is called "Med-South." All who take part will receive Med-South dietary counseling. In addition, to help participants follow a Med-style dietary pattern, one group of study participants will receive extra virgin olive oil and nuts. The other group will receive extra virgin olive oil, nuts, and frozen meals (medically tailored meals) that align with the Med-South dietary pattern. Participants will be assigned at random (like flipping a coin) to one of these groups

Study Overview

Detailed Description

For those taking part in this study, participation study will last from the enrollment visit (staring as early as possible during the 1st trimester, but < 15 weeks of pregnancy) to delivery-for most this will be about 24 weeks, but less for those who deliver early. There will be 10 counseling sessions throughout the study. Three sessions will be in-person and will include study measures. The other 7 sessions can be done over the phone or in person. Also, there are 4 optional phone counseling sessions. Each session will last approximately 10-45 minutes (except the first session, which may last an hour).

The risk of taking part in this study is minimal as the dietary pattern being tested is NOT experimental. This study is promoting a diet pattern that aligns with the United States Department of Agriculture (USDA) 2020-25 guidelines for people who are pregnant. A risk of all research studies is loss of confidentiality, but the study team will take all standard measures to reduce this risk.

In terms of benefits, if one takes part in this study and follows the dietary recommendations, pregnancy outcomes may be improved. Also, the food received as part of this study may be considered a benefit.

Both intervention groups will receive nuts and olive oil valued at $50 per month for up to 6 months (time of delivery). Participants in the group that only receives olive oil and nuts will also receive a grocery store gift card each month for up to 6 months (or time of delivery) while those in the group receiving medically tailored meals will receive 7 frozen meals a week for up to 6 months (or time of delivery).

Study Type

Interventional

Enrollment (Actual)

35

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Chapel Hill, North Carolina, United States, 27599
        • Center for Health Promotion and Disease Prevention/UNC-Chapel Hill

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age 18 or older
  • Patient plans to receive prenatal care at UNC OB/GYN at Weaver Crossing
  • Patient deemed to have viable singleton pregnancy and approved for participation by OB clinician
  • Gestational age < 15 weeks
  • Patient able to consume nuts, EVOO, or both

Exclusion Criteria:

  • Patient is not fluent in English
  • Patient does not have access to internet by web, tablet, or smart phone
  • Type 1 diabetes
  • Pregnant with twins or a greater number of fetuses

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Nuts and Extra Virgin Olive Oil
Intervention includes lifestyle counseling and food provisions including extra virgin olive oil (EVOO) and nuts
Intervention includes lifestyle counseling and food provisions including extra virgin olive oil and nuts
Experimental: Nuts, Extra Virgin Olive Oil, and Medically Tailored Meals
Intervention includes lifestyle counseling and food provisions including extra virgin olive oil (EVOO), nuts, and medically tailored meals
Intervention includes lifestyle counseling and food provisions including extra virgin olive oil, nuts, and medically tailored meals

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percent that would recommend this program to others who are pregnancy
Time Frame: Assessed at approximately 24 and 36 weeks of pregnancy
Percent who report they strongly agree or agree (other options on scale -- neither, agree, strongly disagree) with the statement: "I would recommend this program to others who are pregnant."
Assessed at approximately 24 and 36 weeks of pregnancy
Percent of participants who take part in the 10 study counseling sessions
Time Frame: from enrollment to delivery (approximately 40 weeks of pregnancy)
Percentage of participants who attend at 8 of the 10 sessions
from enrollment to delivery (approximately 40 weeks of pregnancy)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal diet quality
Time Frame: Assessed at approximately 24 and 36 weeks of pregnancy
Quality of diet during pregnancy assessed with modified Prevención con Dieta Mediterránea (PREDIMED) study screener. The modified PREDIMED screener consists of 12 items, each scored as healthful or not (1 for healthful and 0 for not healthful), with items summed for a total score.
Assessed at approximately 24 and 36 weeks of pregnancy

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
skin carotenoids
Time Frame: Assessed at approximately 24 and 36 weeks of pregnancy
Assessed by Reflection Spectroscopy Device ("Veggie Meter"™). Results is a score that reflects skin carotenoid content with is correlated with fruit and vegetable intake. The score is assessed 3 times and averaged.
Assessed at approximately 24 and 36 weeks of pregnancy

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Thomas Keyserling, MD, University of North Carollina at Chapel Hill

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 10, 2024

Primary Completion (Actual)

July 5, 2025

Study Completion (Actual)

July 5, 2025

Study Registration Dates

First Submitted

April 15, 2024

First Submitted That Met QC Criteria

April 15, 2024

First Posted (Actual)

April 18, 2024

Study Record Updates

Last Update Posted (Actual)

August 22, 2025

Last Update Submitted That Met QC Criteria

August 21, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 24-0181

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy Complications

Clinical Trials on Med-South Lifestyle Intervention for Pregnancy--Arm 1

Subscribe